Overview
Cyrus Khan is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Khan has been practicing medicine for over 15 years and is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed Refractory Multiple Myeloma (RRMM), Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 23 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4800 Friendship Ave, Pittsburgh, PA 15224
320 E N Ave, Pittsburgh, PA 15212
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
University Of Pittsburgh Physicians, Department Of Medicine
Warren D. Shlomchik, MD, is professor of medicine and immunology at the University of Pittsburgh School of Medicine. He is director of Hematopoietic Stem Cell Transplant and Cell Therapy and scientific director of the Hematopoietic Malignancy Program at UPMC Hillman Cancer Center. Dr. Shlomchik;s research is dedicated to understanding the complex immunology of allogeneic hematopoietic stem cell transplantation (alloSCT), including graft-versus host disease (GVHD), graft-versus-leukemia (GVL), and immune reconstitution. Read more about Dr. Shlomchik's research. Dr. Shlomchik is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Monongalia County General Hospital Company
Michael Craig is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Craig is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Craig is currently accepting new patients.
UPMC Hillman Cancer Center
Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health. Dr. Ito is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Khan isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Chronic B-Cell Leukemia (CBCL)Dr. Khan isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Khan isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Multiple MyelomaDr. Khan isDistinguished. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Khan isAdvanced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Khan isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Khan isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Khan isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid Leukemia
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Khan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Khan isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Khan isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Khan isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Khan isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaDr. Khan isExperienced. Learn about Anaplastic Large Cell Lymphoma.